Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy

NCT02806752 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Wet Macular Degeneration

Interventions

DRUG: Triamcinolone Acetonide
DRUG: Ranibizumab

Sponsor

Aier School of Ophthalmology, Central South University